drugset / Trial / NCT01431053
Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer
RandomizedParallel-groupOpen-labelPrevention
Summary
This is a phase II study to assess efficacy/safety of Exemestane with or without Aspirin as the adjuvant treatment in postmenopausal breast cancer patients.
Timeline
- Start
- 2011-07
- Primary completion
- 2014-07
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 50 mg | Oral |
| Subject | Exemestane | Small molecule | 25 mg | Oral |